Drug Stocks Favored by Funds

Description:

According to Robert Holmes, "Drug stocks such as Johnson & Johnson (JNJ) and Gilead Sciences (GILD) have been beaten up in the year since the health-care reform bill was passed. That may soon change, as fund managers are pouncing on shares of undervalued companies." Here are the health-care equity picks of two fund managers and an analyst. Read more here.

>>Also: 10 Buy-Rated Stocks Under $5

>>Also: 4 Small Stocks With Buyout Rumors

Most Viewed Portfolios

View All

Articles

5 Toxic Stocks You Need to Sell Now

08.29.14 | 12:32 PM

BALTIMORE (Stockpickr) -- The S&P 500 is quickly closing in on the double-digit gains mark this summer, up more that 8% year-to-date as I write. At...

5 Breakout Stocks Under $10 Set to Soar

08.28.14 | 02:41 PM

DELAFIELD, Wis. (Stockpickr) -- There isn't a day that goes by on Wall Street when certain stocks trading for under $10 a share don't experience m...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter